High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis

Hypocalcemia is the most common major adverse event in patients with osteoporosis receiving the bone resorption inhibitor denosumab; however, limited information is available regarding risk factors of hypocalcemia. Therefore, this study aimed to identify the risk factors of hypocalcemia induced by d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Koji, Nagai, Takashi, Sakamoto, Keizo, Ohara, Kenji, Eguro, Takeshi, Ito, Hiroshi, Toyoshima, Yoichi, Kokaze, Akatsuki, Toyone, Tomoaki, Inagaki, Katsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147395/
https://www.ncbi.nlm.nih.gov/pubmed/27980413
http://dx.doi.org/10.2147/TCRM.S123172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147395/
https://www.ncbi.nlm.nih.gov/pubmed/27980413
http://dx.doi.org/10.2147/TCRM.S123172

Ejemplares similares